A prospective study of Alzheimer disease in Down syndrome

F. Lai and R. S. Williams
Eunice Kennedy Shriver Center, Waltham, Mass 02254.

Ninety-six individuals with Down syndrome over age 35 years were evaluated and followed up for evidence of nontreatable dementia. Dementia was judged to be present when a functional decline occurred in areas such as orientation, memory, verbal and motor skills, and self-care abilities. Forty-nine patients with Down syndrome fit this criterion, with an average onset of dementia at 54.2 +/- 6.1 years. The prevalence of dementia in the institutionalized Down syndrome population of our study (n = 53) was 8% (2/25 patients) between 35 and 49 years, 55% (11/20 patients) between 50 and 59 years, and 75% (6/8 patients) of those over 60 years old. Of note, 41 (84%) demented individuals with Down syndrome developed seizures. Ten (20%) had parkinsonian features. Adequately treated hypothyroidism was present in 27 (59%) of 46 demented patients with Down syndrome tested. The average duration of dementia in the 23 patients who died was 4.6 +/- 3.2 years. Computed tomographic scans in 43 patients all showed brain tissue loss, most pronounced in the temporal lobes. Brains from 12 autopsied cases showed large numbers of plaques and tangles in the same locations as in persons with Alzheimer disease.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Elevated Plasma beta-Amyloid Peptide Abeta42 Levels, Incident Dementia, and Mortality in Down Syndrome
Schupf et al.
Arch Neurol 2007;64:1007-1013.
ABSTRACT | FULL TEXT  

The subjective experience of individuals with Down syndrome living with dementia
Lloyd et al.
Dementia 2007;6:63-88.
ABSTRACT  

Phenotype associated with APP duplication in five families
Cabrejo et al.
Brain 2006;129:2966-2976.
ABSTRACT | FULL TEXT  

Alzheimer's dementia in persons with Down's syndrome: Predicting time spent on day-to-day caregiving
McCarron et al.
Dementia 2005;4:521-538.
ABSTRACT  

Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry
Teipel et al.
Brain 2004;127:811-824.
ABSTRACT | FULL TEXT  

Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
Haier et al.
Neurology 2003;61:1673-1679.
ABSTRACT | FULL TEXT  

Relation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down's Syndrome
Teipel et al.
Am. J. Psychiatry 2003;160:1870-1878.
ABSTRACT | FULL TEXT  

Why Wait for Dementia?
Watchman
J Intellect Disabil 2003;7:221-230.
ABSTRACT  

Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force
Boustani et al.
ANN INTERN MED 2003;138:927-937.
ABSTRACT | FULL TEXT  

Adverse effects of phenytoin given for late-onset seizures in adults with Down syndrome
Tsiouris et al.
Neurology 2002;59:779-780.
FULL TEXT  

Genetic and host factors for dementia in Down's syndrome
SCHUPF and Sergievsky
Br. J. Psychiatry 2002;180:405-410.
ABSTRACT | FULL TEXT  

APOE {epsilon}4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
DEB et al.
Br. J. Psychiatry 2000;176:468-472.
ABSTRACT | FULL TEXT  

Temporal Accrual of Complement Proteins in Amyloid Plaques in Down’s Syndrome with Alzheimer’s Disease
Stoltzner et al.
Am. J. Pathol. 2000;156:489-499.
ABSTRACT | FULL TEXT  

High Brain myo-Inositol Levels in the Predementia Phase of Alzheimer’s Disease in Adults With Down’s Syndrome: A 1H MRS Study
Huang et al.
Am. J. Psychiatry 1999;156:1879-1886.
ABSTRACT | FULL TEXT  

APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
Lai et al.
Neurology 1999;53:331-331.
ABSTRACT | FULL TEXT  

MRI Volumes of the Hippocampus and Amygdala in Adults With Down's Syndrome With and Without Dementia
Aylward et al.
Am. J. Psychiatry 1999;156:564-568.
ABSTRACT | FULL TEXT